💊 Betamethasone (Calcipotriene And Betamethasone Dipropionate)
A topical suspension combining a vitamin D analog and a corticosteroid, used to treat plaque psoriasis of the scalp and body. It is for use on the skin only, not by mouth, in the eyes, or in the vagina. Your doctor or pharmacist sets the dose and duration of treatment for you.
In Arabic: كالسيبوترين وبيتاميثازون ديبروبيونات (معلّق موضعي)✅ What it is used for
- Topical treatment of plaque psoriasis of the scalp in patients 12 years and older
- Topical treatment of plaque psoriasis of the scalp and body in patients 18 years and older
🧪 Active ingredient
Calcipotriene is a synthetic vitamin D3 analog. Betamethasone dipropionate is a synthetic corticosteroid. The product combines both pharmacological effects, although the exact mechanism of action in plaque psoriasis is unknown.
🌿 Benefits
- Topical treatment for plaque psoriasis of the scalp and body
- Applied once daily
📝 How to use
- Shake the bottle before use.
- Apply to affected areas of the scalp and body once daily for up to 8 weeks; the dose and duration are set by your doctor or pharmacist.
- Stop when control is achieved.
- Wash your hands after applying.
- Do not bathe, shower, or wash your hair right after application.
- Do not use with occlusive dressings unless directed by a healthcare provider.
- Do not use on the face, groin, or axillae, or if skin atrophy is present at the treatment site.
- Do not apply to the scalp in the 12 hours before or after chemical hair treatments.
- Not for oral, ophthalmic, or intravaginal use.
💊 Dosage forms
- Topical suspension 0.005%/0.064%: each gram contains 50 mcg calcipotriene and 0.643 mg betamethasone dipropionate
- 60 gram bottle (and a 120 gram pack of two 60 g bottles)
⚠️ Common side effects
- Folliculitis
- Burning sensation of skin
- Itching (pruritus)
- Skin irritation
- Redness (erythema)
- Exacerbation of psoriasis
🚨 Serious — seek medical help
- Hypercalcemia and hypercalciuria
- HPA axis suppression with potential glucocorticosteroid insufficiency
- Possible increased risk of cataracts and glaucoma
- In pediatric patients: rarely Cushing's syndrome, linear growth retardation, delayed weight gain, intracranial hypertension; striae
⛔ Do not use if
- None listed in the label
❗ Warnings & precautions
- Hypercalcemia and hypercalciuria: if either occurs, stop treatment until calcium metabolism normalizes.
- HPA axis suppression: risk increases with large surface area, prolonged use, occlusion, altered skin barrier, liver failure, and young age.
- May increase the risk of cataracts and glaucoma; consider ophthalmology referral if visual symptoms occur.
- Do not exceed 60 g per week (ages 12–17) or 100 g per week (adults).
- Hypercalcemia incidence with use beyond 8 weeks has not been evaluated.
🔄 Drug interactions
- No drug interaction information is provided in the label text supplied.
🤰 Pregnancy
Data are insufficient to evaluate the risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Observational studies suggest an increased risk of low birth weight infants with maternal use of potent or super potent topical corticosteroids. Use on the smallest area of skin for the shortest duration possible, after consulting your doctor. Animal studies showed fetal toxicity and malformations.
🍼 Breastfeeding
The label text supplied does not include breastfeeding information; consult your doctor before use.
🧒 Children
Safety and effectiveness are established for scalp psoriasis in ages 12 to 17 years; not established under 12 years. Pediatric patients are at greater risk than adults of HPA axis suppression and systemic toxicity.
👴 Older adults
No overall differences in safety or effectiveness were observed between elderly and younger subjects, but greater sensitivity in some older individuals cannot be ruled out.
🌡️ Storage
Store at 20° to 25°C (68° to 77°F); do not refrigerate. Keep the bottle in the carton when not in use and shake before use. Discard unused product six months after opening. Keep out of reach of children.
⏰ Missed dose
The label text supplied does not give instructions for a missed dose; ask your doctor or pharmacist.
🆘 Overdose
The label text supplied does not describe overdose. Excessive use may increase the risk of hypercalcemia and HPA axis suppression; contact your doctor if you used more than prescribed.
💰 Price & brands in your area
🏛️ Official price in Palestine — Ministry of Health price list:
| Product | Company | Pack | Price |
|---|---|---|---|
| VALECORT-G OINTMENT Betamethasone (as Valerate) 0.1%, Gentamycin (Sulphate) 0.1% | BPC | tube | 15 ₪ |
| VALECORT-G.CREAM Betamethasone (as Valerate) 0.1%, Gentamycin (Sulphate) 0.1% | BPC | tube | 15 ₪ |
| DELECAS Inj. 1 ML BETAMETHASONE AS ( DIPROPIONATE & SOD. PHOSPHATE ) | BPC | 1 Amp. of 1ML | 20 ₪ |
| SIDI-ZONE CREAM Fusidic acid+Betamethasone | Sama Pharmaceutical. Co. | 15GM | 30 ₪ |
| DELECAS Inj. 2 ML BETAMETHASONE AS ( DIPROPIONATE & SOD. PHOSPHATE ) | BPC | 1 Amp.of 2ML | 36 ₪ |
| BETACALCIP TEVA TUBE 30G Calcipotriol 50 mcg / 1g and Betamethasone (as diptopionate) 0.5 mg/1g | Teva | 30 G | 59 ₪ |
| BETACALCIP TEVA TUBE 60G Calcipotriol 50 mcg / 1g and Betamethasone (as diptopionate) 0.5 mg/1g | Teva | 60 G | 113 ₪ |
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Combines calcipotriene (synthetic vitamin D3 analog) and betamethasone dipropionate (synthetic corticosteroid); pharmacologic and clinical effects are known, but the exact mechanism in plaque psoriasis is unknown.
Labeled dosing
Adults: apply to affected scalp and body areas once daily for up to 8 weeks, discontinuing when control is achieved; maximum 100 g per week. Ages 12–17: up to 60 g per week. The final dose is determined by the doctor or pharmacist.
- Monitor calcium if hypercalcemia is suspected; discontinue until normalized.
- HPA axis suppression may be evaluated with the ACTH stimulation test; if documented, withdraw gradually, reduce application frequency, or substitute a less potent steroid.
- In a 4-week trial in adolescents, HPA axis suppression occurred in 3% (scalp) and 16% (scalp and body).
- Most common adverse reactions (≥1%): folliculitis and burning sensation of skin.
- No contraindications are listed.
🎓 Key points for students
- Combination of a vitamin D analog and a corticosteroid for plaque psoriasis.
- Key warnings: hypercalcemia/hypercalciuria, HPA axis suppression, cataracts and glaucoma.
- HPA suppression risk factors: large surface area, prolonged use, occlusion, altered skin barrier, liver failure, young age.
- Weekly maximum: 60 g (12–17 years) and 100 g (adults).
- Not for oral, ophthalmic, or intravaginal use.
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
What is this medicine used for?
Plaque psoriasis of the scalp (age 12 and older) and of the scalp and body (age 18 and older).
How long is it used?
Once daily for up to 8 weeks, stopping when control is achieved; your doctor or pharmacist sets the dose and duration.
Can I shower right after applying it?
No. Do not bathe, shower, or wash your hair right after application, and wash your hands afterward.
Can it be used on the face?
No. It should not be used on the face, groin, or axillae.
What are the most common side effects?
Folliculitis and a burning sensation of the skin.
Is it safe in pregnancy?
It may increase the risk of a low birth weight infant; use on the smallest area for the shortest time and only after consulting your doctor.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2025-07), simplified. Updated: 2026-11-16.